Mike Halpin

Michael Halpin is the current Chief Operating Officer at Vericel Corporation since April 2017. Prior to that, Michael held various positions at Sanofi Genzyme, including Senior Vice President Quality and Regulatory Affairs. With a background in biomedical and medical engineering from the University of Virginia, Michael has extensive experience in quality and regulatory affairs in the healthcare industry, including roles at MediSense, Abbott Laboratories Medisense Products, and Abiomed.